Loading...
The company posted a strong start to 2025 with core sales growth of 5%, improved adjusted EBITDA margin, and significant shareholder returns. Operating and net income rose year-over-year.
Net sales reached $388,800,000, a 4% increase year-over-year.
Adjusted EPS improved to $0.31, up from $0.29 last year.
Adjusted EBITDA margin increased by 110 basis points to 25.2%.
Zurn Elkay repurchased $77,000,000 worth of shares during the quarter.
The company expects core sales growth in the low to mid-single digits for Q2 2025 and reaffirms its full-year outlook.